Palantir Technologies (PLTR) fell 3.67% in Thursday trading to $143.98 as investors continued trimming exposure to high-multiple AI/software stocks. The decline fits a broader pattern of rotation out of expensive AI winners, where small sentiment shifts can trigger outsized moves in names with elevated valuation multiples. (tipranks.com)

Adding to the risk-off tone, new U.K. reporting highlighted pushback from staff, lawmakers, and unions around the NHS Federated Data Platform and discussed the possibility of the government weighing a break clause that could end the contract early in 2027. Even if there is no immediate financial impact, the headlines increase perceived political/regulatory risk and can pressure the stock on a down tape. (techradar.com)

With PLTR up sharply from prior years and still widely viewed as pricing in aggressive growth, traders have been quick to take profits into any uncertainty, especially when AI/software sentiment softens. In this setup, contract headlines—positive or negative—can act as catalysts for short-term de-risking rather than long-term fundamental re-rating. (tipranks.com)

Traders will be watching for any follow-on developments related to the NHS contract timeline and scope, plus any fresh government award headlines that could shift the narrative back toward backlog and revenue visibility. Separately, continued sector flows will matter: if high-multiple software stays under pressure, PLTR can remain volatile even without company-specific news. (techradar.com)